Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000930413-09-003603
Filing Date
2009-07-10
Accepted
2009-07-10 13:48:23
Documents
1
Period of Report
2009-07-01

Document Format Files

Seq Description Document Type Size
1 c58210_ex.html 3  
1 c58210_ex.xml 3 1648
  Complete submission text file 0000930413-09-003603.txt   3337
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /DE/ (Issuer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 165 LUDLOW AVE. NORTHVALE NJ 07647
Business Address
Ward Carter Julian (Reporting) CIK: 0001467874 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15697 | Film No.: 09939637